At a glance
- Originator Aventis; Bayer
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 15 Aug 1995 No-Development-Reported for HIV infections treatment in Germany (unspecified route)
- 01 Dec 1994 Preclinical development for HIV infections treatment in Germany (unspecified route)